Breaking News Instant updates and real-time market news.

GILD

Gilead

$62.50 /

-0.54 (-0.86%)

, VIR

Vir Biotechnology

$28.30 /

+0.46 (+1.65%)

08:11
01/12/21
01/12
08:11
01/12/21
08:11

Gilead, Vir Biotechnology establish collaboration for chronic HBV

Gilead Sciences (GILD) and Vir Biotechnology (VIR) announced that the companies have entered into a clinical collaboration to evaluate novel therapeutic combination strategies aimed at developing a functional cure for chronic hepatitis B virus. The companies plan to initiate a Phase 2 trial evaluating combination therapy for both treatment-experienced and treatment-naive people living with HBV. The multi-arm trial will evaluate different combinations of selgantolimod, Gilead's investigational TLR-8 agonist; VIR-2218, Vir's investigational small interfering ribonucleic acid; and a commercially-sourced, marketed PD-1 antagonist. People in the trial with HBV treatment experience may also receive Gilead's Vemlidy. The primary outcome of the study will be the proportion of patients achieving a functional cure, defined as an off-therapy loss of hepatitis B surface antigen and HBV DNA from the serum. Both companies retain full rights to their individual product candidates and will discuss the potential path forward for any future combination studies based on the outcome of the Phase 2 trial.

GILD

Gilead

$62.50 /

-0.54 (-0.86%)

VIR

Vir Biotechnology

$28.30 /

+0.46 (+1.65%)

  • 08

    Jul

GILD Gilead
$62.50 /

-0.54 (-0.86%)

01/11/21 Piper Sandler
Piper says hard for Gilead investors to ascribe long-term value to Veklury
01/04/21 Guggenheim
Gilead upgraded to Buy from Neutral at Guggenheim
12/22/20 Citi
Gilead price target lowered to $72 from $75 at Citi
12/18/20 Truist
Gilead price target lowered to $62 from $67 at Truist
VIR Vir Biotechnology
$28.30 /

+0.46 (+1.65%)

12/24/20 Baird
Baird maintains 'profound skepticism' of Vir's COVID antibody after Lilly data
10/07/20 Goldman Sachs
Goldman says Lilly comments support need for multiple COVID-19 antibody makers
10/07/20 H.C. Wainwright
Vir Biotechnology price target raised to $100 from $80 at H.C. Wainwright
10/05/20
Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Downgrade
Taiheiyo Cement downgraded to Neutral from Buy at Mizuho » 05:22
02/25/21
02/25
05:22
02/25/21
05:22
THYCY

Taiheiyo Cement

$0.00 /

+ (+0.00%)

Mizuho analyst Hiroshi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Nike upgraded to Buy from Hold at HSBC » 05:22
02/25/21
02/25
05:22
02/25/21
05:22
NKE

Nike

$135.79 /

-0.35 (-0.26%)

HSBC analyst Erwan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$135.79 /

-0.35 (-0.26%)

NKE Nike
$135.79 /

-0.35 (-0.26%)

02/05/21 Citi
Foot Locker upgraded to Buy from Neutral at Citi
02/05/21 Citi
Citi sees 'many reasons' for why Nike should acquire Foot Locker
02/03/21 Jefferies
Under Armour price target raised to $25 from $23 at Jefferies
01/25/21 KeyBanc
Nike price target raised to $180 from $174 at KeyBanc
NKE Nike
$135.79 /

-0.35 (-0.26%)

NKE Nike
$135.79 /

-0.35 (-0.26%)

NKE Nike
$135.79 /

-0.35 (-0.26%)

NKE Nike
$135.79 /

-0.35 (-0.26%)

Earnings
NetEase reports Q4 EPS 36c, consensus 45c » 05:21
02/25/21
02/25
05:21
02/25/21
05:21
NTES

NetEase

$117.62 /

-2.69 (-2.24%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTES NetEase
$117.62 /

-2.69 (-2.24%)

NTES NetEase
$117.62 /

-2.69 (-2.24%)

02/16/21 Barclays
NetEase price target raised to $155 from $110 at Barclays
12/31/20
NetEase initiated with an Outperform at Industrial Securities
11/02/20 Goldman Sachs
NetEase price target raised to $107 from $104 at Goldman Sachs
10/07/20 Citi
NetEase price target lowered to $106 from $112.60 at Citi
NTES NetEase
$117.62 /

-2.69 (-2.24%)

NTES NetEase
$117.62 /

-2.69 (-2.24%)

NTES NetEase
$117.62 /

-2.69 (-2.24%)

NTES NetEase
$117.62 /

-2.69 (-2.24%)

Upgrade
Dixons Carphone upgraded to Buy from Hold at Investec » 05:21
02/25/21
02/25
05:21
02/25/21
05:21
DSITF

Dixons Carphone

$0.00 /

+ (+0.00%)

Investec analyst Benedict…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DSITF Dixons Carphone
$0.00 /

+ (+0.00%)

01/18/21 RBC Capital
Dixons Carphone upgraded to Outperform from Sector Perform at RBC Capital
12/17/20 Barclays
Dixons Carphone price target raised to 145 GBp from 120 GBp at Barclays
10/16/20 RBC Capital
Dixons Carphone upgraded to Sector Perform from Underperform at RBC Capital
09/04/20 Exane BNP Paribas
Dixons Carphone downgraded to Neutral from Outperform at Exane BNP Paribas
Upgrade
NXP Semiconductors upgraded to Buy from Neutral at Citi » 05:19
02/25/21
02/25
05:19
02/25/21
05:19
NXPI

NXP Semiconductors

$186.31 /

+5.27 (+2.91%)

Citi analyst Christopher…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NXPI NXP Semiconductors
$186.31 /

+5.27 (+2.91%)

NXPI NXP Semiconductors
$186.31 /

+5.27 (+2.91%)

02/17/21 Wells Fargo
Wells says NXP plants in Austin make up less than 30% of production sq. footage
02/03/21
Fly Intel: Top five analyst upgrades
02/03/21
NXP Semiconductors price target raised to $223 from $200 at Needham
02/03/21 Credit Suisse
NXP Semiconductors price target raised to $215 from $175 at Credit Suisse
NXPI NXP Semiconductors
$186.31 /

+5.27 (+2.91%)

NXPI NXP Semiconductors
$186.31 /

+5.27 (+2.91%)

NXPI NXP Semiconductors
$186.31 /

+5.27 (+2.91%)

NXPI NXP Semiconductors
$186.31 /

+5.27 (+2.91%)

Earnings
Youdao reports Q4 EPS (58c), consensus (70c) » 05:18
02/25/21
02/25
05:18
02/25/21
05:18
DAO

Youdao

$30.20 /

+0.695 (+2.36%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DAO Youdao
$30.20 /

+0.695 (+2.36%)

DAO Youdao
$30.20 /

+0.695 (+2.36%)

01/04/21 Macquarie
Youdao initiated with an Outperform at Macquarie
01/04/21 Macquarie
Youdao initiated with an Outperform at Macquarie
10/22/20 Nomura
Nomura downgrades GSX Techedu to Reduce, cuts target to 'Street-low' $38
09/02/20
Fly Intel: Top five analyst downgrades
DAO Youdao
$30.20 /

+0.695 (+2.36%)

  • 11
    Feb
DAO Youdao
$30.20 /

+0.695 (+2.36%)

Upgrade
Suzuki Motor upgraded to Outperform from Neutral at Daiwa » 05:18
02/25/21
02/25
05:18
02/25/21
05:18
SZKMY

Suzuki Motor

$0.00 /

+ (+0.00%)

Daiwa analyst Eiji…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SZKMY Suzuki Motor
$0.00 /

+ (+0.00%)

10/03/20 Goldman Sachs
Suzuki Motor upgraded to Conviction Buy from Buy at Goldman Sachs
08/28/20 Daiwa
Suzuki Motor downgraded to Neutral from Outperform at Daiwa
03/17/20 Nomura Instinet
Suzuki Motor upgraded to Neutral from Reduce at Nomura Instinet
Downgrade
Solon Eiendom downgraded to Hold from Buy at DNB Markets » 05:17
02/25/21
02/25
05:17
02/25/21
05:17
BNRPF

Solon Eiendom

$0.00 /

+ (+0.00%)

DNB Markets analyst Simen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Downgrade
Scor downgraded to Hold from Buy at Commerzbank » 05:16
02/25/21
02/25
05:16
02/25/21
05:16
SCRYY

Scor

$0.00 /

+ (+0.00%)

Commerzbank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SCRYY Scor
$0.00 /

+ (+0.00%)

01/12/21 Berenberg
Scor price target raised to EUR 36 from EUR 32 at Berenberg
12/17/20 Bryan Garnier
Scor downgraded to Buy from Conviction Buy at Bryan Garnier
11/30/20 Morgan Stanley
Scor price target raised to EUR 36 from EUR 33 at Morgan Stanley
11/18/20 RBC Capital
Scor upgraded to Outperform from Sector Perform at RBC Capital
Upgrade
GB Group upgraded to Buy from Hold at Stifel » 05:15
02/25/21
02/25
05:15
02/25/21
05:15
GBGPF

GB Group

$0.00 /

+ (+0.00%)

Stifel analyst Bridie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GBGPF GB Group
$0.00 /

+ (+0.00%)

10/29/20 Panmure Gordon
GB Group upgraded to Buy from Hold at Panmure Gordon
10/20/20 Berenberg
GB Group upgraded to Buy from Hold at Berenberg
10/12/20 Citi
Citi opens 'positive catalyst watch' on GB Group
10/07/20 Canaccord
GB Group upgraded to Buy from Hold at Canaccord
Upgrade
JCR Pharmaceuticals upgraded to Outperform from Neutral at Credit Suisse » 05:14
02/25/21
02/25
05:14
02/25/21
05:14
JCRRF

JCR Pharmaceuticals

$0.00 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
TD Holdings subsidiary granted Dangerous Chemicals Business License » 05:14
02/25/21
02/25
05:14
02/25/21
05:14
GLG

TD Holdings

$2.44 /

+0.14 (+6.09%)

TD Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GLG TD Holdings
$2.44 /

+0.14 (+6.09%)

Upgrade
Vestas upgraded to Buy from Neutral at UBS » 05:13
02/25/21
02/25
05:13
02/25/21
05:13
VWDRY

Vestas

$0.00 /

+ (+0.00%)

UBS analyst Supriya…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VWDRY Vestas
$0.00 /

+ (+0.00%)

02/11/21 Deutsche Bank
Vestas price target lowered to DKK 1,460 from DKK 1,500 at Deutsche Bank
02/08/21 Deutsche Bank
Vestas price target lowered to DKK 1,500 from DKK 1,630 at Deutsche Bank
02/08/21 SEB Equities
Vestas downgraded to Hold from Buy at SEB Equities
01/15/21 Morgan Stanley
Vestas price target raised to DKK 1,099 from DKK 1,066 at Morgan Stanley
Hot Stocks
Xencor, UCLA TDG collaborate to develop XmAb therapeutics » 05:12
02/25/21
02/25
05:12
02/25/21
05:12
XNCR

Xencor

$48.58 /

+0.09 (+0.19%)

Xencor and UCLA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XNCR Xencor
$48.58 /

+0.09 (+0.19%)

XNCR Xencor
$48.58 /

+0.09 (+0.19%)

02/24/21 Piper Sandler
Xencor remains a top pick for 2021 at Piper Sandler
02/24/21 RBC Capital
Xencor price target raised to $59 from $48 at RBC Capital
02/24/21 Raymond James
Xencor upgraded to Outperform from Market Perform at Raymond James
02/24/21 Barclays
Xencor price target raised to $34 from $31 at Barclays
XNCR Xencor
$48.58 /

+0.09 (+0.19%)

Upgrade
AstraZeneca upgraded to Buy from Neutral at UBS » 05:11
02/25/21
02/25
05:11
02/25/21
05:11
AZN

AstraZeneca

$49.17 /

+0.81 (+1.67%)

UBS analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$49.17 /

+0.81 (+1.67%)

AZN AstraZeneca
$49.17 /

+0.81 (+1.67%)

02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
01/22/21 Barclays
AstraZeneca price target lowered to 9,000 GBp from 9,300 GBp at Barclays
01/19/21 BTIG
Adaptive Biotechnologies price target raised to $74 from $66 at BTIG
AZN AstraZeneca
$49.17 /

+0.81 (+1.67%)

AZN AstraZeneca
$49.17 /

+0.81 (+1.67%)

AZN AstraZeneca
$49.17 /

+0.81 (+1.67%)

AZN AstraZeneca
$49.17 /

+0.81 (+1.67%)

General news
FX Action: USD-CAD has posted a three-year low » 05:10
02/25/21
02/25
05:10
02/25/21
05:10

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Earnings
Vipshop reports Q4 EPS 54c, consensus 49c » 05:07
02/25/21
02/25
05:07
02/25/21
05:07
VIPS

Vipshop

$36.39 /

-0.07 (-0.19%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIPS Vipshop
$36.39 /

-0.07 (-0.19%)

VIPS Vipshop
$36.39 /

-0.07 (-0.19%)

02/01/21 Morgan Stanley
Vipshop user engagement to underpin 'solid' user growth, says Morgan Stanley
02/01/21 Morgan Stanley
Vipshop upgraded to Overweight from Underweight at Morgan Stanley
01/26/21 KeyBanc
Vipshop downgraded to Sector Weight at KeyBanc on lack of drivers
01/26/21 KeyBanc
Vipshop downgraded to Sector Weight from Overweight at KeyBanc
VIPS Vipshop
$36.39 /

-0.07 (-0.19%)

VIPS Vipshop
$36.39 /

-0.07 (-0.19%)

VIPS Vipshop
$36.39 /

-0.07 (-0.19%)

VIPS Vipshop
$36.39 /

-0.07 (-0.19%)

Recommendations
Elastic price target raised to $185 from $175 at Jefferies » 05:05
02/25/21
02/25
05:05
02/25/21
05:05
ESTC

Elastic

$157.48 /

+4.36 (+2.85%)

Jefferies analyst Brent…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESTC Elastic
$157.48 /

+4.36 (+2.85%)

ESTC Elastic
$157.48 /

+4.36 (+2.85%)

02/19/21 RBC Capital
Elastic price target raised to $175 from $155 at RBC Capital
01/21/21 Goldman Sachs
Elastic initiated with a Neutral at Goldman Sachs
01/19/21 Truist
Elastic initiated with a Buy at Truist
01/15/21 Stifel
Elastic upgraded to Buy after licensing changes at Stifel
ESTC Elastic
$157.48 /

+4.36 (+2.85%)

ESTC Elastic
$157.48 /

+4.36 (+2.85%)

Upgrade
National Bank of Canada upgraded to Outperform from Market Perform at BMO » 05:03
02/25/21
02/25
05:03
02/25/21
05:03
NTIOF

National Bank of Canada

$0.00 /

+ (+0.00%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTIOF National Bank of Canada
$0.00 /

+ (+0.00%)

02/17/21 Scotiabank
National Bank of Canada price target raised to C$89 from C$88 at Scotiabank
02/16/21 Barclays
National Bank of Canada price target raised to C$81 from C$78 at Barclays
12/03/20 TD Securities
National Bank of Canada price target raised to C$79 from C$78 at TD Securities
12/03/20 BMO Capital
National Bank of Canada price target raised to C$77 from C$72 at BMO Capital
Recommendations
Vapotherm price target lowered to $36 from $39 at Piper Sandler » 05:01
02/25/21
02/25
05:01
02/25/21
05:01
VAPO

Vapotherm

$26.99 /

-0.42 (-1.53%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VAPO Vapotherm
$26.99 /

-0.42 (-1.53%)

VAPO Vapotherm
$26.99 /

-0.42 (-1.53%)

01/15/21 Piper Sandler
Vapotherm price target raised to $39 from $36 at Piper Sandler
01/13/21 Piper Sandler
Vapotherm remains top small pick at Piper Sandler
12/17/20
Fly Intel: Top five analyst initiations
12/17/20 Piper Sandler
Vapotherm initiated with an Overweight at Piper Sandler
VAPO Vapotherm
$26.99 /

-0.42 (-1.53%)

  • 07
    May
VAPO Vapotherm
$26.99 /

-0.42 (-1.53%)

VAPO Vapotherm
$26.99 /

-0.42 (-1.53%)

Recommendations
Redfin price target raised to $99 from $73 at Piper Sandler » 05:00
02/25/21
02/25
05:00
02/25/21
05:00
RDFN

Redfin

$91.61 /

+0.95 (+1.05%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDFN Redfin
$91.61 /

+0.95 (+1.05%)

RDFN Redfin
$91.61 /

+0.95 (+1.05%)

02/23/21 Truist
Redfin price target raised to $102 from $84 at Truist
02/19/21 Piper Sandler
Redfin purchase of RentPath 'strategically compelling,' says Piper Sandler
02/05/21 Goldman Sachs
Redfin upgraded to Neutral from Sell at Goldman Sachs
01/20/21 DA Davidson
Redfin downgraded to Neutral from Buy at DA Davidson
RDFN Redfin
$91.61 /

+0.95 (+1.05%)

RDFN Redfin
$91.61 /

+0.95 (+1.05%)

RDFN Redfin
$91.61 /

+0.95 (+1.05%)

Recommendations
Booking Holdings price target raised to $2,345 from $1,709 at Piper Sandler » 04:59
02/25/21
02/25
04:59
02/25/21
04:59
BKNG

Booking Holdings

$2,431.90 /

+69.05 (+2.92%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKNG Booking Holdings
$2,431.90 /

+69.05 (+2.92%)

BKNG Booking Holdings
$2,431.90 /

+69.05 (+2.92%)

02/22/21 Credit Suisse
Booking Holdings price target raised to $2,430 from $2,170 at Credit Suisse
02/18/21 Deutsche Bank
Booking Holdings price target raised to $2,680 from $2,585 at Deutsche Bank
01/28/21 Wells Fargo
Booking Holdings price target raised to $2,250 from $1,800 at Wells Fargo
01/21/21 Truist
Booking Holdings price target raised to $2480 from $2120 at Truist
BKNG Booking Holdings
$2,431.90 /

+69.05 (+2.92%)

BKNG Booking Holdings
$2,431.90 /

+69.05 (+2.92%)

BKNG Booking Holdings
$2,431.90 /

+69.05 (+2.92%)

BKNG Booking Holdings
$2,431.90 /

+69.05 (+2.92%)

Downgrade
Chuy's downgraded to Market Perform from Outperform at BMO Capital » 04:56
02/25/21
02/25
04:56
02/25/21
04:56
CHUY

Chuy's

$43.99 /

+1.58 (+3.73%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHUY Chuy's
$43.99 /

+1.58 (+3.73%)

02/10/21 Raymond James
Chuy's downgraded to Market Perform at Raymond James on valuation
02/10/21 Raymond James
Chuy's downgraded to Market Perform from Outperform at Raymond James
01/15/21 Stifel
Chuy's upgraded to Buy from Hold at Stifel
11/16/20 BMO Capital
Chuy's upgraded to Outperform from Market Perform at BMO Capital
CHUY Chuy's
$43.99 /

+1.58 (+3.73%)

Initiation
I-MAB initiated with an Overweight at Piper Sandler » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
IMAB

I-MAB

$57.93 /

+0.58 (+1.01%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMAB I-MAB
$57.93 /

+0.58 (+1.01%)

IMAB I-MAB
$57.93 /

+0.58 (+1.01%)

12/07/20 H.C. Wainwright
I-MAB initiated with a Buy at H.C. Wainwright
09/08/20 Cantor Fitzgerald
I-MAB price target raised to $55 from $50 at Cantor Fitzgerald
07/27/20 Cantor Fitzgerald
I-MAB initiated with an Overweight at Cantor Fitzgerald
  • 09
    Feb
  • 13
    Jan
IMAB I-MAB
$57.93 /

+0.58 (+1.01%)

Conference/Events
Twitter to host virtual analyst day » 04:55
02/25/21
02/25
04:55
02/25/21
04:55
TWTR

Twitter

$71.91 /

-1.27 (-1.74%)

Virtual Analyst Day to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 6 minutes

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$71.91 /

-1.27 (-1.74%)

TWTR Twitter
$71.91 /

-1.27 (-1.74%)

02/22/21 Baird
Twitter price target raised to $75 from $65 at Baird
02/18/21 JPMorgan
JPMorgan still prefers Twitter to Snap into analyst days next week
02/16/21 Loop Capital
Twitter price target raised to $95 from $56 at Loop Capital
02/11/21
Fly Intel: Top five analyst upgrades
TWTR Twitter
$71.91 /

-1.27 (-1.74%)

TWTR Twitter
$71.91 /

-1.27 (-1.74%)

TWTR Twitter
$71.91 /

-1.27 (-1.74%)

TWTR Twitter
$71.91 /

-1.27 (-1.74%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.